BackCo-Diagnostics Overview

Co-Diagnostics Short-Term Investments

Co-Diagnostics's short-term investments is $0.

Get informed when a big investor buys or sells

+ Follow
Short-Term Investments
$0.00
↓ 100.00% YoYΔ $-2.25M vs prior year quarter

Peer trimmed avg / median

Loading

Co-Diagnostics Short-Term Investments History

Loading

Co-Diagnostics vs. peers: Short-Term Investments Comparison

Loading

Co-Diagnostics Short-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Co-Diagnostics (CODX) FAQ

The latest short-term investments for CODX is $0 as of June 2026. That compares with $2.2M in the prior-year period — down 100.0% year over year. Investors often review this figure alongside Co-Diagnostics's historical trend and sector peers before judging valuation or financial health.

Over the past year, CODX's short-term investments moved from $2.2M to $0 — a 100.0% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Co-Diagnostics's operating scale or balance-sheet position.

A short-term investments figure of $0 for CODX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CODX's short-term investments ($0), review year-over-year change from $2.2M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Co-Diagnostics's short-term investments against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.